![Cerevance](https://www.adcreviews.com/wp-content/uploads/2022/08/Cerevance-300x137.jpeg)
Merck and Cerevance collaborate to explore new targets for Alzheimer’s disease
On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover